Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of Improving Risk Stratification in Brugada Syndrome

NCT03992677 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT03992677
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03992677 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of Improving Risk Stratification in Brugada Syndrome
Lead sponsor
Imperial College London
Phase
Observational
Overall status
Completed
Start date
December 1, 2017
Completion date
August 1, 2022
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

athletes heart, atrial fibrillation, brugada syndrome, cardiac arrest, ventricular ectopic beat